April 24, 2023: The Pharma Letter – FDA lifts clinical hold of MaaT Pharma’s lead microbiome therapeutic trial

Date : May 3, 2023

[image_with_animation image_url=”9994″ animation=”Fade In” hover_animation=”none” alignment=”center” border_radius=”none” box_shadow=”none” image_loading=”default” max_width=”100%” max_width_mobile=”default” img_link=”https://www.thepharmaletter.com/article/fda-lifts-clinical-hold-of-maat-pharma-s-lead-microbiome-therapeutic-trial”]